Neonatal Seizures: Dilemmas in Workup and Management

Pediatric Neurology

Volumn 38, Issue 6, 2008, Pages 415-421

  Bassan, Haim ^a   Bental, Yoram ^b   Shany, Eilon ^c   Berger, Itai ^d   Froom, Paul ^e   Levi, Loren ^a   Shiff, Yakov ^b  

^a Dana Children's Hospital   (Israel)

^b LANIADO HOSPITAL   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^e TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CHLORAL HYDRATE; CLONAZEPAM; DIAZEPAM; LAMOTRIGINE; LIDOCAINE; LORAZEPAM; MIDAZOLAM; PARALDEHYDE; PHENOBARBITAL; PHENYTOIN; TOPIRAMATE; VALPROIC ACID;

ANALYTIC METHOD; ARTICLE; ASPHYXIA; BLEEDING; CONTROLLED STUDY; ELECTROENCEPHALOGRAPHY; HUMAN; PEDIATRICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; SEIZURE;

ANTICONVULSANTS; BRAIN; DATA COLLECTION; DRUG UTILIZATION; ELECTROENCEPHALOGRAPHY; HUMANS; INFANT, NEWBORN; ISRAEL; LABORATORY TECHNIQUES AND PROCEDURES; MENINGOENCEPHALITIS; QUESTIONNAIRES; SEIZURES;

EID: 43649108515     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2008.03.003     Document Type: Article

References (52)

1. Neonatal seizures. In: Volpe J.J. (Ed). Neurology of the newborn. 4th ed. (2001), Saunders, Philadelphia 178-214
2. Tekgul H., Gauvreau K., Soul J., et al. The current etiologic profile and neurodevelopmental outcome of seizures in term newborn infants. Pediatrics 117 (2006) 1270-1280
3. Ronen G.M., Penney S., and Andrews W. The epidemiology of clinical neonatal seizures in Newfoundland: A population-based study. J Pediatr 134 (1999) 71-75
4. Evans D., and Levene M. Neonatal seizures. Arch Dis Child Fetal Neonatal Ed 78 (1998) F70-F75
5. Painter M. Neonatal seizure disorders. In: Levene I.M. (Ed). Fetal and neonatal neurology and neurosurgery. 2nd ed (1995), Churchill Livingstone, Edinburgh 547-561
6. Scher M.S. Neonatal seizures and brain damage. Pediatr Neurol 29 (2003) 381-390
7. Holmes G.L. Effects of seizures on brain development: Lessons from the laboratory. Pediatr Neurol 33 (2005) 1-11
8. Lombroso C.T. Neonatal seizures: Gaps between the laboratory and the clinic. Epilepsia 48 Suppl. 2 (2007) 83-106
9. Hunt R.W., and Inder T.E. Neonatal seizures: Have we got the treatment right. J Paediatr Child Health 41 (2005) 311-312
10. Clancy R.R. The newborn drug development initiative workshop: Summary proceedings from the Neurology Group on Neonatal Seizures. Clin Ther 28 (2006) 1342-1352
11. Cornejo B.J., Mesches M.H., Coultrap S., Browning M.D., and Benke T.A. A single episode of neonatal seizures permanently alters glutamatergic synapses. Ann Neurol 61 (2007) 411-426
12. Bartha A.I., Shen J., Katz K.H., et al. Neonatal seizures: Multicenter variability in current treatment practices. Pediatr Neurol 37 (2007) 85-90
13. Carmo K.B., and Barr P. Drug treatment of neonatal seizures by neonatologists and paediatric neurologists. J Paediatr Child Health 41 (2005) 313-316
14. Wheless J.W., Clarke D.F., and Carpenter D. Treatment of pediatric epilepsy: Expert opinion, 2005. J Child Neurol 20 Suppl. 1 (2005) S1-S56
15. Painter M.J., Scher M.S., Stein A.D., et al. Phenobarbital compared with phenytoin for the treatment of neonatal seizures. N Engl J Med 341 (1999) 485-489
16. Evans D., Levene M., and Tsakmakis M. Anticonvulsants for preventing mortality and morbidity in full term newborns with perinatal asphyxia. Cochrane Database Syst Rev (2007) CD001240
17. Clancy R.R. Summary proceedings from the Neurology Group on Neonatal Seizures. Pediatrics 117 Suppl. (2006) S23-S27
18. Hellstrom-Westas L., Westgren U., Rosen I., and Svenningsen N.W. Lidocaine for treatment of severe seizures in newborn infants. I. Clinical effects and cerebral electrical activity monitoring. Acta Paediatr Scand 77 (1988) 79-84
19. Rey E., Radvanyi-Bouvet M.F., Bodiou C., et al. Intravenous lidocaine in the treatment of convulsions in the neonatal period: Monitoring plasma levels. Ther Drug Monit 12 (1990) 316-320
20. Hellstrom-Westas L., Svenningsen N.W., Westgren U., Rosen I., and Lagerstrom P.O. Lidocaine for treatment of severe seizures in newborn infants. II. Blood concentrations of lidocaine and metabolites during intravenous infusion. Acta Paediatr Scand 81 (1992) 35-39
21. Castro Conde J.R., Hernandez Borges A.A., Domenech Martinez E., Gonzalez Campo C., and Perera Soler R. Midazolam in neonatal seizures with no response to phenobarbital. Neurology 64 (2005) 876-879
22. Boylan G.B., Rennie J.M., Chorley G., et al. Second-line anticonvulsant treatment of neonatal seizures: A video-EEG monitoring study. Neurology 62 (2004) 486-488
23. Shany E., Benzaqen O., and Watemberg N. Comparison of continuous drip of midazolam or lidocaine in the treatment of intractable neonatal seizures. J Child Neurol 22 (2007) 255-259
24. Malingre M.M., Van Rooij L.G., Rademaker C.M., et al. Development of an optimal lidocaine infusion strategy for neonatal seizures. Eur J Pediatr 165 (2006) 598-604
25. Cha B.H., Silveira D.C., Liu X., Hu Y., and Holmes G.L. Effect of topiramate following recurrent and prolonged seizures during early development. Epilepsy Res 51 (2002) 217-232
26. Wirrell E.C. Neonatal seizures: To treat or not to treat. Semin Pediatr Neurol 12 (2005) 97-105
27. Schubert S., Brandl U., Brodhun M., et al. Neuroprotective effects of topiramate after hypoxia-ischemia in newborn piglets. Brain Res 1058 (2005) 129-136
28. Zhao Q., Hu Y., and Holmes G.L. Effect of topiramate on cognitive function and activity level following neonatal seizures. Epilepsy Behav 6 (2005) 529-536
29. Watemberg N., Goldberg-Stern H., Ben-Zeev B., et al. Clinical experience with open-label topiramate use in infants younger than 2 years of age. J Child Neurol 18 (2003) 258-262
30. Alfonso I., Alvarez L.A., Gilman J., Dunoyer C., Yelin K., and Papazian O. Intravenous valproate dosing in neonates. J Child Neurol 15 (2000) 827-829
31. Hellstrom-Westas L., Blennow G., Lindroth M., Rosen I., and Svenningsen N.W. Low risk of seizure recurrence after early withdrawal of antiepileptic treatment in the neonatal period. Arch Dis Child Fetal Neonatal Ed 72 (1995) F97-F101
32. Ellison P.H., Largent J.A., and Bahr J.P. A scoring system to predict outcome following neonatal seizures. J Pediatr 99 (1981) 455-459
33. Guillet R., and Kwon J. Seizure recurrence and developmental disabilities after neonatal seizures: Outcomes are unrelated to use of phenobarbital prophylaxis. J Child Neurol 22 (2007) 389-395
34. Diaz J., Schain R.J., and Bailey B.G. Phenobarbital-induced brain growth retardation in artificially reared rat pups. Biol Neonate 32 (1977) 77-82
35. Schain R.J., and Watanabe K. Effect of chronic phenobarbital administration upon brain growth of the infant rat. Exp Neurol 47 (1975) 509-515
36. Cowan F., Mercuri E., Groenendaal F., et al. Does cranial ultrasound imaging identify arterial cerebral infarction in term neonates?. Arch Dis Child Fetal Neonatal Ed 90 (2005) F252-F256
37. Leijser L.M., de Vries L.S., and Cowan F.M. Using cerebral ultrasound effectively in the newborn infant. Early Hum Dev 82 (2006) 827-835
38. Donnelly L.F., Emery K.H., Brody A.S., et al. Minimizing radiation dose for pediatric body applications of single-detector helical CT: Strategies at a large children's hospital. AJR 176 (2001) 303-306
39. Filan P.M., Inder T.E., Anderson P.J., Doyle L.W., and Hunt R.W. Monitoring the neonatal brain: A survey of current practice among Australian and New Zealand neonatologists. J Paediatr Child Health 43 (2007) 557-559
40. Boer H.R., and Gal P. Neonatal seizures: A survey of current practice. Clin Pediatr (Phila) 21 (1982) 453-457
41. Clancy R., Legido A., and Lewis D. Occult neonatal seizures. Epilepsia 29 (1988) 256-261
42. Scher M.S., Alvin J., Gaus L., Minnigh B., and Painter M.J. Uncoupling of EEG-clinical neonatal seizures after antiepileptic drug use. Pediatr Neurol 28 (2003) 277-280
43. Hellstrom-Westas L., Rosen I., and Swenningsen N.W. Silent seizures in sick infants in early life. Diagnosis by continuous cerebral function monitoring. Acta Paediatr Scand 74 (1985) 741-748
44. Toet M.C., Groenendaal F., Osredkar D., van Huffelen A.C., and de Vries L.S. Postneonatal epilepsy following amplitude-integrated EEG-detected neonatal seizures. Pediatr Neurol 32 (2005) 241-247
45. Shany E., Khvatskin S., Golan A., and Karplus M. Amplitude-integrated electroencephalography: A tool for monitoring silent seizures in neonates. Pediatr Neurol 34 (2006) 194-199
46. Evans D.J., and Levene M.I. Anticonvulsants for preventing mortality and morbidity in full term newborns with perinatal asphyxia. Cochrane Database Syst Rev (2001) CD001240
47. Booth D., and Evans D.J. Anticonvulsants for neonates with seizures. Cochrane Database Syst Rev (2004) CD004218
48. Zupanc M.L. Neonatal seizures. Pediatr Clin North Am 51 (2004) 961-978
49. Miller S.P., Weiss J., Barnwell A., et al. Seizure-associated brain injury in term newborns with perinatal asphyxia. Neurology 58 (2002) 542-548
50. McBride M.C., Laroia N., and Guillet R. Electrographic seizures in neonates correlate with poor neurodevelopmental outcome. Neurology 55 (2000) 506-513
51. Boylan G.B., Pressler R.M., Rennie J.M., et al. Outcome of electroclinical, electrographic, and clinical seizures in the newborn infant. Dev Med Child Neurol 41 (1999) 819-825
52. Scher M.S., Trucco G.S., Beggarly M.E., Steppe D.A., and Macpherson T.A. Neonates with electrically confirmed seizures and possible placental associations. Pediatr Neurol 19 (1998) 37-41